BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 14/08/2026

FDA Clears LASIX Tablets for Sale, Citing Lack of Safety or Effectiveness Concerns

The US Food and Drug Administration has ruled that LASIX tablets, available in 20mg, 40mg, and 80mg doses, were not withdrawn from the market due to safety or effectiveness issues, allowing the agency to continue approving abbreviated new drug applications for the product.

Source: Federal Register — Health and Human ServicesOpen original release →